Eleven Biotherapeutics CEO Thomas Cannell's 2022 pay falls 72% to $1.4M

Eleven Biotherapeutics reports 2022 executive compensation

By ExecPay News

Published: April 28, 2023

Eleven Biotherapeutics reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Eleven Biotherapeutics received on average a compensation package of $991K, a 63% decrease compared to previous year.
Average pay of disclosed executives at Eleven Biotherapeutics
Thomas R. Cannell, Chief Executive Officer, received $1.4M in total, which decreased by 72% compared to 2021. 58% of Cannell's compensation, or $814K, was in stock awards. Cannell also received $577K in salary and $4K in other compensation.
Monica Forbes, Chief Financial Officer, received a compensation package of $889K, which decreased by 53% compared to previous year. 55% of the compensation package, or $485K, was in stock awards.
Mark Sullivan, General Counsel, earned $690K in 2022.

Related executives

Thomas Cannell

Eleven Biotherapeutics

Chief Executive Officer

Monica Forbes

Eleven Biotherapeutics

Chief Financial Officer

Mark Sullivan

Eleven Biotherapeutics

General Counsel

You may also like

Source: SEC filing on April 28, 2023.